These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 1359451

  • 1. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
    Robertson GS, Vincent SR, Fibiger HC.
    Neuroscience; 1992 Jul; 49(2):285-96. PubMed ID: 1359451
    [Abstract] [Full Text] [Related]

  • 2. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.
    Robertson GS, Jian M.
    Neuroscience; 1995 Feb; 64(4):1019-34. PubMed ID: 7753373
    [Abstract] [Full Text] [Related]

  • 3. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Robertson GS.
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [Abstract] [Full Text] [Related]

  • 4. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
    Le Moine C, Svenningsson P, Fredholm BB, Bloch B.
    J Neurosci; 1997 Oct 15; 17(20):8038-48. PubMed ID: 9315922
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR.
    Science; 1990 Dec 07; 250(4986):1429-32. PubMed ID: 2147780
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons.
    Jian M, Staines WA, Iadarola MJ, Robertson GS.
    Brain Res Mol Brain Res; 1993 Jul 07; 19(1-2):156-60. PubMed ID: 7689681
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF, Cole BN, LaHoste GJ.
    Brain Res; 1993 Dec 31; 632(1-2):308-13. PubMed ID: 7908600
    [Abstract] [Full Text] [Related]

  • 10. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML, Currie RW, Robertson HA.
    Neuroscience; 1995 May 31; 66(2):347-59. PubMed ID: 7477877
    [Abstract] [Full Text] [Related]

  • 11. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 May 31; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 12. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Turgeon SM, Fink JS.
    Neuroscience; 1997 Jul 31; 79(1):79-93. PubMed ID: 9178866
    [Abstract] [Full Text] [Related]

  • 13. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus.
    Brog JS, Zahm DS.
    Neuroscience; 1996 Oct 31; 74(3):805-12. PubMed ID: 8884776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.
    Svenningsson P, Fourreau L, Bloch B, Fredholm BB, Gonon F, Le Moine C.
    Neuroscience; 1999 Mar 31; 89(3):827-37. PubMed ID: 10199616
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.
    Carta AR, Frau L, Pinna A, Morelli M.
    Exp Neurol; 2010 Aug 31; 224(2):395-402. PubMed ID: 20452347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.